Clin2
NCT07220408Possibly a fitRecruiting

TL-925 eye drops for seasonal eye allergies

Allergic Conjunctivitis

Part of Eyes & vision, Immune system & allergy clinical trials.

This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a history of eye allergies and a positive allergy skin test to seasonal or year-round allergens
  • You are not currently pregnant, and if you or your partner can become pregnant, you agree to use effective birth control during the study
  • You have not had any eye surgery in the last 3 months or laser vision correction in the last 6 months
  • You do not have any eye infection or other eye condition that could interfere with the study results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686472Recruiting· Phase 2
Testing TL-925 eye drops for allergic conjunctivitis

This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.

Memphis, Tennessee
NCT07309432Recruiting· Phase 3
Birch allergy shot study for eye symptoms

This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.

Andover, Massachusetts
NCT06577077Not yet recruiting· Phase 3
Testing a new medicine for year-round allergies

This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.

NCT07395232Recruiting· Phase 3
Testing a new drug for allergic eye disease (AKC)

This study tests a new medication called DFL24498 for people with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The goal is to see if it reduces itching, discomfort, and eye redness safely.

Jacksonville, Florida
NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT07273747Recruiting
Kelulut honey for eye allergy and dry eye

This study tests if Kelulut honey eye drops can help people with both allergic conjunctivitis (eye allergies) and dry eye symptoms. If you have been diagnosed with eye allergies and still have bothersome symptoms despite treatment, this trial may offer a natural option to explore.

Kota Bharu, Kelantan

Hear when a new Allergic Conjunctivitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.